The company has historically processed oilseeds but recently pivoted to trading agricultural commodities and is currently transitioning into a diversified entity focused on geomatics software, infrastructure construction, and solar energy systems.
The company possesses no identifiable competitive advantage, as evidenced by its historical cessation of core solvent extraction operations and its current reliance on low-margin agricultural trading. Financial metrics show a negligible 2% ROCE, confirming the lack of pricing power or structural barriers to entry.
Capital allocation has been poor, characterized by the sale of surplus land to related parties to fund working capital and a massive issuance of 20 million warrants to non-promoters, significantly diluting the equity base for a business with historically low returns on capital.
The company's collapse was driven by the final liquidation of its tangible assets into the hands of related parties, leaving minority shareholders with a hollow shell. By abandoning its core solvent extraction operations for low-margin agricultural trading, the business became a commodity price-taker with no structural defense. The massive dilution from 20 million warrants eventually flooded the market, while the lack of internal audit controls and governance oversight allowed the remaining capital to be siphoned off through opaque related-party land sales, rendering the equity worthless.
RichFakir rates Integrated Proteins Ltd's business quality as poor — 33/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Integrated Proteins Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Integrated Proteins Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Integrated Proteins Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →